BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32150484)

  • 21. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
    Cheng LC; Murugaiyah V; Chan KL
    J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Oshima S; Shiiya S; Nakamura Y
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
    Cicero AFG; Caliceti C; Fogacci F; Giovannini M; Calabria D; Colletti A; Veronesi M; Roda A; Borghi C
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28755406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Inositol Hexaphosphate (IP
    Ikenaga T; Kakumoto K; Kohda N; Yamamoto T
    Plant Foods Hum Nutr; 2019 Sep; 74(3):316-321. PubMed ID: 31119466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
    Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
    Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial.
    Shi Y; Williamson G
    Br J Nutr; 2016 Mar; 115(5):800-6. PubMed ID: 26785820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice.
    Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q
    Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.
    Dalbeth N; Saag KG; Palmer WE; Choi HK; Hunt B; MacDonald PA; Thienel U; Gunawardhana L
    Arthritis Rheumatol; 2017 Dec; 69(12):2386-2395. PubMed ID: 28975718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S50-6. PubMed ID: 21654270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypouricemic Effect of Ethanol Extract of
    Park JE; Yeom Z; Park KT; Han EH; Yu HJ; Kang HS; Lim YH
    Clin Nutr Res; 2018 Apr; 7(2):126-135. PubMed ID: 29713621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study.
    Hosoya T; Sasaki T; Ohashi T
    Clin Rheumatol; 2017 Mar; 36(3):649-656. PubMed ID: 27832384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.
    Sircar D; Chatterjee S; Waikhom R; Golay V; Raychaudhury A; Chatterjee S; Pandey R
    Am J Kidney Dis; 2015 Dec; 66(6):945-50. PubMed ID: 26233732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvia plebeia Extract Inhibits Xanthine Oxidase Activity In Vitro and Reduces Serum Uric Acid in an Animal Model of Hyperuricemia.
    Kim JK; Kim WJ; Hyun JM; Lee JS; Kwon JG; Seo C; Song MJ; Choi CW; Hong SS; Park K; Kim P; Sung H; Lee JK; Choi Y
    Planta Med; 2017 Nov; 83(17):1335-1341. PubMed ID: 28521370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Toona sinensis Leaf Extract and Its Chemical Constituents on Xanthine Oxidase Activity and Serum Uric Acid Levels in Potassium Oxonate-Induced Hyperuricemic Rats.
    Yuk HJ; Lee YS; Ryu HW; Kim SH; Kim DS
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544886
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
    Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia.
    Usharani P; Nutalapati C; Pokuri VK; Kumar CU; Taduri G
    Clin Pharmacol; 2016; 8():51-9. PubMed ID: 27382337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.